Merck & Co. Inc. | 2013 | FY | 3


A reconciliation between the effective tax rate and the U.S. statutory rate is as follows:
 
2013
 
2012
 
2011
  
Amount
 
Tax Rate
 
Amount
 
Tax Rate
 
Amount
 
Tax Rate
U.S. statutory rate applied to income before taxes
$
1,941

 
35.0
 %
 
$
3,059

 
35.0
 %
 
$
2,567

 
35.0
 %
Differential arising from:
 
 
 
 
 
 
 
 
 
 
 
Foreign earnings
(1,316
)
 
(23.7
)
 
(1,955
)
 
(22.4
)
 
(2,220
)
 
(30.3
)
Tax settlements
(497
)
 
(9.0
)
 
(113
)
 
(1.3
)
 
(721
)
 
(9.8
)
The American Taxpayer Relief Act of 2012
(269
)
 
(4.8
)
 

 

 

 

Unremitted foreign earnings
(81
)
 
(1.5
)
 
(11
)
 
(0.1
)
 
(86
)
 
(1.2
)
Tax rate changes
(10
)
 
(0.2
)
 
57

 
0.6

 
(295
)
 
(4.0
)
Amortization of purchase accounting adjustments
934

 
16.8

 
905

 
10.3

 
875

 
11.9

Restructuring
224

 
4.0

 
62

 
0.7

 
163

 
2.2

U.S. health care reform legislation
65

 
1.2

 
60

 
0.7

 
50

 
0.7

Intangible asset impairment charges
56

 
1.0

 
40

 
0.5

 
(5
)
 
(0.1
)
Vioxx and ENHANCE litigation settlements

 

 
98

 
1.2

 

 

Arbitration settlement charge

 

 

 

 
177

 
2.4

State taxes
44

 
0.8

 
31

 
0.3

 
72

 
1.0

Other (1)
(63
)
 
(1.1
)
 
207

 
2.4

 
365

 
5.0

 
$
1,028

 
18.5
 %
 
$
2,440

 
27.9
 %
 
$
942

 
12.8
 %
(1) 
Other includes the tax effect of contingency reserves, research credits and miscellaneous items.

us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock